ENHANCING CANCER TREATMENT BY COMBINING TRADITIONAL KNOWLEDGE FROM KORAPUT DISTRICT WILD MEDICINAL TUBERS WITH STRUCTURE-BASED VIRTUAL SCREENING OF ANAPLASTIC LYMPHOMA KINASE INHIBITORS

Authors

  • SAMEER JENA Department of Botany, School of Applied Sciences, Centurion University of Technology and Management, Odisha, India. https://orcid.org/0009-0009-2429-1416
  • IPSITA PRIYADARSINI SAMAL Department of Botany, School of Applied Sciences, Centurion University of Technology and Management, Odisha, India.
  • RAM BABU Department of Botany, Kirori Mal College, University of Delhi, Delhi, India.
  • NIKHIL RANJAN BEHERA School of Life Sciences, Sambalpur University, Burla, Odisha, India https://orcid.org/0009-0005-4926-620X
  • SNIGDHA BEHERA Department of Botany, School of Applied Sciences, Centurion University of Technology and Management, Odisha, India https://orcid.org/0009-0006-1515-0839
  • DILESWAR SAHU P.G. Department of Botany, Panchayat Degree College, Bargarh, Odisha, India. https://orcid.org/0009-0008-2582-8767
  • GYANRANJAN MAHALIK Department of Botany, School of Applied Sciences, Centurion University of Technology and Management, Odisha, India https://orcid.org/0000-0003-4953-9982

DOI:

https://doi.org/10.22159/ajpcr.2026v19i3.57699

Keywords:

ALK inhibitor, Anti-cancer, Ethnobotany, wild edible plants, medicinal plants, tribal communities, nutritional analysis, Virtual Screening

Abstract

Objective: This study aimed to document the ethnobotanical uses of wild edible medicinal tubers and rhizomes consumed by tribal communities in Koraput district, Odisha, India, to evaluate their nutritional composition, and to identify potential phytochemicals as anaplastic lymphoma kinase (ALK) inhibitors for cancer therapy through structure-based virtual screening (SBVS).

Methods: Ethnobotanical data were collected through semi-structured interviews, focus group discussions, and participant observation with tribal communities in the Koraput district over 18 months (January 2023–June 2024). Twenty-seven wild edible medicinal plant species with underground storage organs were identified and authenticated with herbarium voucher specimens. Nutritional analysis was performed using standard Association of Official Analytical Chemists methods to determine protein, carbohydrate, fat, fiber, mineral, and vitamin content. For computational drug discovery, 793 phytomolecules from these 27 plants were retrieved from the : Indian Medicinal Plants, Phytochemistry and Therapeutics (IMPPAT) database and subjected to SBVS against the ALK protein (PDB ID: 4FOB) using AutoDock Vina. Compounds with favorable binding affinities were further evaluated for drug-likeness, Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties using SwissADME and ProTox-III, and molecular dynamics (MD) stability using iMODS and CABSflex servers.

Results: The study documented 27 species across 13 plant families, with Zingiberaceae being the most represented (11 species, 40.7%). Tubers (15 species) and rhizomes (12 species) were the primary plant parts used, traditionally employed to treat 23 different ailments, predominantly gastrointestinal disorders. Nutritional analysis revealed significant levels of essential nutrients: proteins (8.5–15.2%), carbohydrates (45.8–72.3%), dietary fiber (12.4–28.7%), and various minerals and vitamins. Virtual screening of 793 phytomolecules identified eight compounds with binding energies better than −7 kcal/mol against ALK. After toxicity profiling, three compounds in toxicity class 6 (non-toxic, LD50 > 5000 mg/kg) were identified as safe candidates. Gibberellic acid (IMPHY011559) from Datura stramonium exhibited the highest binding affinity (−8.6 kcal/mol) and favorable ADMET properties. MD simulations confirmed the stability of the ALK-gibberellic acid complex.

Conclusion: Wild medicinal tubers and rhizomes represent underutilized resources that bridge traditional knowledge and modern nutritional science, offering solutions for malnutrition and health challenges in tribal populations. The integration of ethnobotanical knowledge with computational drug discovery identified gibberellic acid as a promising ALK inhibitor candidate. These findings support the incorporation of indigenous knowledge systems into nutrition and healthcare practices while highlighting the potential of culturally relevant phytochemicals for cancer treatment. However, these in silico predictions require validation through in vitro and in vivo experimental studies.

Downloads

Download data is not yet available.

References

1. Satapathy MK, Bisoi SS. Indigenous knowledge and practices on conservation of natural resources by tribal communities of Koraput district, Odisha, India. Environ Ecol. 2021;39:216-99.

2. Panda D, Behera RK, Behera PK, Padhi SK, Nayak JK. Nutritional and nutraceutical potential of underutilised wild flowers used by tribal people of Koraput for Health Benefit. Proc Natl Acad Sci India Sect B Biol Sci. 2024 Feb;94(1):201-7. doi: 10.1007/s40011-023-01520-0

3. Cohen AJ, Pope, Pope CA. Lung cancer and air pollution. Environ Health Perspect. 1995 Nov;103 Suppl 8:219-24. doi: 10.1289/ ehp.95103s8219, PMID 8741787

4. Jena S, Samal IP, Mohanty P, Dash SS, Babu R, Mahalik G. Ethnopharmacological and nutritional evaluation of wild edible plants in Koraput District, Odisha. Asian J Pharm Clin Res. Aug 2025;18(8):102-10. doi: 10.22159/ajpcr.2025v18i8.55039

5. Qu D, Yan A. Classification models and SAR analysis of anaplastic lymphoma kinase (ALK) inhibitors using machine learning algorithms with two data division methods. Mol Divers. 2025 Aug;29(4):2919-43. doi: 10.1007/s11030-024-10990-x, PMID 39531134

6. Bhoi DK, Ahirwar RK. Traditional medicine insights: Exploring ethnomedicinal leafy vegetables of the Bhunjia and Paharia tribes in Sunabeda Wildlife Sanctuary, Odisha, India. Genet Resour Crop Evol. 2025 Feb;72(2):2077-101. doi: 10.1007/s10722-024-02082-4

7. Uprety Y, Poudel RC, Shrestha KK, Rajbhandary S, Tiwari NN, Shrestha UB, et al. Diversity of use and local knowledge of wild edible plant resources in Nepal. J Ethnobiol Ethnomed. 2012 Apr 30;8(1):16. doi: 10.1186/1746-4269-8-16, PMID 22546349

8. Sreekumar VB, Sreejith KA, Hareesh VS, Sanil MS. An overview of wild edible fruits of Western Ghats, India. Genet Resour Crop Evol. 2020 Oct;67(7):1659-93. doi: 10.1007/s10722-020-00986-5

9. Sharma A, Wagh VV. From forests to tables: Wild edible plants’ contribution to ethnomedicine and nutrition in northeastern Madhya Pradesh, India. Genet Resour Crop Evol. 2025 Apr;72(4):4205-39. doi: 10.1007/s10722-024-02206-w

10. Alrhmoun M, Sulaiman N, Pieroni A. Phylogenetic perspectives and ethnobotanical insights on wild edible plants of the Mediterranean, Middle East, and North Africa. Foods. 2025 Feb 1;14(3):465. doi: 10.3390/foods14030465, PMID 39942057

11. Krochmal-Marczak B, Sawicka B, Barbaś P, Pszczółkowski P, Ziarati P. Medicinal plants: Uses, cultivation, and preservation. In: Sawicka B, Messaoudi M, Rebiai A, editors. In: Biotechnology and Phytochemical Prospects in Drug Discovery. Singapore: Springer Nature; 2025 Apr 23. p. 7-81. doi: 10.1007/978-981-96-2790-5_2

12. Ouarghidi A, Gary JM, Abbad A. Botanical identification and ethno-medicinal uses of some underground part of medicinal plants collected and traded in Marrakech region. J Med Plants Res. 2013 Aug 14;7(29):2165-9. doi: 10.5897/JMPR11.1597

13. Bisoi SS, Panda D. Ethno-medicinal plants present in sacred groves of Koraput district of Odisha, India. Acta Biomed Sci. 2015;2(1):39-42.

14. Mishra M, Sujana KA, Dhole PA. Ethnomedicinal plants used for the treatment of cuts and wounds by tribes of Koraput in Odisha, India. Indian J Plant Sci. 2016;5:14-9.

15. Shin JW, Kim N, Minh NT, Chapagain DD, Jee SH. Serum bilirubin subgroups and cancer risk: Insights with a focus on lung cancer. Cancer Epidemiol. 2025 Feb 1;94:102727. doi: 10.1016/j.canep.2024.102727, PMID 39675260

16. Nie H, Zhang S, Wang L, Wang M, Qiu J, Jia F, et al. Synthesis of novel deuterated EGFR/ALK dual-target inhibitors and their activity against non-small cell lung cancer. Eur J Med Chem. 2025 Feb 5;283:117146. doi: 10.1016/j.ejmech.2024.117146, PMID 39657459

17. Zha Z, Liu C, Yan M, Chen C, Yu C, Chen Y, et al. RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer. Signal Transduct Target Ther. 2025 Apr 18;10(1):124. doi: 10.1038/s41392-025-02206-x, PMID 40246819

18. Wang F, Li Z, Long X, He Q, Huang W, Wu D, et al. Real-world data on the efficacy and safety of iruplinalkib (WX-0593) in ALK-positive advanced lung adenocarcinoma patients previously treated with lorlatinib. JCO. 2025;43(16_suppl):8638. doi: 10.1200/ JCO.2025.43.16_suppl.8638

19. Dash CJ, Adhikary PP, Madhu M, Mishra PK. Quantifying forest cover changes in Koraput district, India using remote sensing and GIS. In: Forest Resources Resilience and Conflicts. Amsterdam: Elsevier; 2021 Jan 1. p. 185-91. doi: 10.1016/B978-0-12-822931- 6.00013-7

20. Mishra S, Chaudhury SS. Ethnobotanical flora used by four major tribes of Koraput, Odisha, India. Genet Resour Crop Evol. 2012 Jun;59(5):793-804. doi: 10.1007/s10722-011-9719-0

21. Nayak MK, Deswal D. Social and Infrastructural development of Tribal population in Koraput district of Odisha: A Case Study. Shodh Sari. 2025;4(1):348-60. doi: 10.59231/SARI7799

22. Singh A, Sadangi BN. Livelihood patterns and resource base of tribals in Koraput and Rayagada district of Odisha. Indian Res J Extension Educ. 2012 Jan;12(1S):307-12.

23. Khosla RK. Importance of minor forest produces in tribal livelihood: A study of Koraput District in Odisha. In: Proceedings of the NDIEAS-2024 International Symposium on New Dimensions and Ideas in Environmental Anthropology-2024 (NDIEAS 2024). Vol. 848. Berlin: Springer Nature; 2024 Jun 12.

24. Lyne PD. Structure-based virtual screening: An overview. Drug Discov Today. 2002 Oct 15;7(20):1047-55. doi: 10.1016/S1359- 6446(02)02483-2, PMID 12546894

25. Lewis RT, Bode CM, Choquette DM, Potashman M, Romero K, Stellwagen JC, et al. The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancer. J Med Chem. 2012 Jul 26;55(14):6523-40. doi: 10.1021/jm3005866, PMID 22734674

26. Roskoski R Jr. Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition. Pharmacol Res. 2013 Feb 1;68(1):68-94. doi: 10.1016/j.phrs.2012.11.007, PMID 23201355

27. Issa AA, Ibraheem HH, El-Sayed DS. Computational innovation of in situ metallic elements with zirconia as a novel possible carrier for chemotherapeutic medication. J Mol Model. 2023;30(1):14. doi: 10.1007/s00894-023-05815-x, PMID 38148383

28. Lohachova KO, Sviatenko AS, Kyrychenko A, Ivanov VV, Langer T, Kovalenko SM, et al. Computer-aided drug design of novel nirmatrelvir analogs inhibiting main protease of coronavirus SARS-CoV-2. J Appl Pharm Sci. 2024 May 5;14(5):232-9. doi: 10.7324/JAPS.2024.158114

29. Butt SS, Badshah Y, Shabbir M, Rafiq M. Molecular docking using chimera and autodock vina software for nonbioinformaticians. JMIR Bioinform Biotechnol. 2020 Jun 19;1(1):e14232. doi: 10.2196/14232, PMID 38943236

30. Nguyen NT, Nguyen TH, Pham TN, Huy NT, Bay MV, Pham MQ, et al. Autodock vina adopts more accurate binding poses but autodock4 forms better binding affinity. J Chem Inf Model. 2020;60(1):204-11. doi: 10.1021/acs.jcim.9b00778, PMID 31887035

31. Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein-ligand docking and virtual drug screening with

the AutoDock suite. Nat Protoc. 2016 May;11(5):905-19. doi: 10.1038/ nprot.2016.051, PMID 27077332

32. Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010 Jan 30;31(2):455-61. doi: 10.1002/jcc.21334, PMID 19499576

33. Vivek-Ananth RP, Mohanraj K, Sahoo AK, Samal A. IMPPAT 2.0: An enhanced and expanded phytochemical atlas of Indian medicinal plants. ACS Omega. 2023 Feb 23;8(9):8827-45. doi: 10.1021/ acsomega.3c00156, PMID 36910986

34. Steinbeck C. The evolution of open science in cheminformatics: A journey from closed systems to collaborative innovation. J Cheminform. 2025 Apr 3;17(1):44. doi: 10.1186/s13321-025- 00990-w, PMID 40181430

35. Wang D, Li D, Qin G, Zhang W, Ouyang J, Zhang M, et al. The structural characterization of tumor fusion genes and proteins. Comput Math Methods Med. 2015;2015(1):912742. doi: 10.1155/2015/912742, PMID 26347798

36. Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017 Mar 3;7(1):42717. doi: 10.1038/srep42717, PMID 28256516

37. Franyoto YD, Nurrochmad A, Fakhrudin N, Murrayakoenigii L. Spreng: An updated review of chemical composition, pharmacological effects, and toxicity studies. J Appl Pharm Sci. 2024 Jun 5;14(6):011-27. doi: 10.7324/JAPS.2024.169254

38. Banerjee P, Kemmler E, Dunkel M, Preissner R. ProTox 3.0: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2024 Jul 5;52(W1):W513-20. doi: 10.1093/nar/gkae303, PMID 38647086

39. López-Blanco JR, Aliaga JI, Quintana-Ortí ES, Chacón P. iMODS: Internal coordinates normal mode analysis server. Nucleic Acids Res. 2014 Jul 1;42(Web Server issue):W271-6. doi: 10.1093/nar/gku339, PMID 24771341

40. Nithin C, Fornari RP, Pilla SP, Wroblewski K, Zalewski M, Madaj R, et al. Exploring protein functions from structural flexibility using CABS-flex modeling. Protein Sci. 2024 Sep;33(9):e5090. doi: 10.1002/ pro.5090, PMID 39194135

41. Ali N, Alotaibi FT, Babu MA, Singh TG, Alaseem AM, Tyagi Y, et al. Retrospection of the USFDA-approved halogenated drugs and their implication in medicinal chemistry and drug discovery: A perspective of approved drugs between 2019 and 2024. Arch Pharmazie. 2026 Jan;359(1):e70190. doi: 10.1002/ardp.70190, PMID 41556324

Published

07-03-2026

How to Cite

JENA, SAMEER, et al. “ENHANCING CANCER TREATMENT BY COMBINING TRADITIONAL KNOWLEDGE FROM KORAPUT DISTRICT WILD MEDICINAL TUBERS WITH STRUCTURE-BASED VIRTUAL SCREENING OF ANAPLASTIC LYMPHOMA KINASE INHIBITORS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 19, no. 3, Mar. 2026, pp. 52-64, doi:10.22159/ajpcr.2026v19i3.57699.

Issue

Section

Original Article(s)